"Le Centre Hospitalier Intercommunal de Créteil (CHIC) assure des missions de recours et de proximité tout en proposant des prises en charge d’excellence et innovantes. L’établissement dispose du service d’urgences le plus important du 94. Il propose une prise en charge complète du couple, de la femme et de l’enfant et a également une forte activité en cancérologie. Il dispose d’un service universitaire d’ophtalmologie de pointe. Le CHIC est un hôpital universitaire et un centre de recherche conventionné par la faculté de médecine Paris Est Créteil 94 pour 9 disciplines hospitalo-universitaires. Avec le CHI de Villeneuve St Georges, il appartient au groupement hospitalier de territoire Hôpitaux Confluence Val -de-Marne Essonne."

During the past decade, Chi De Creteil; Ophtalmologie conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chi De Creteil; Ophtalmologie" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chi De Creteil; Ophtalmologie" are "Geographic Atrophy" (4 trials), "Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials) and "Central Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Chi De Creteil; Ophtalmologie" in a lesser frequency.

Most popular intervention types in "Chi De Creteil; Ophtalmologie" are "Drug" (9 trials), "Other" (5 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Lampalizumab" (2 trials) and "No intervention" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chi De Creteil; Ophtalmologie" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Chi De Creteil; Ophtalmologie". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chi De Creteil; Ophtalmologie, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Chi De Creteil; Ophtalmologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".